These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35734620)

  • 1. Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients.
    Feng J; Liang B; Zhang HY; Liu Z; Jiang K; Zhao XQ
    World J Gastrointest Surg; 2022 May; 14(5):442-451. PubMed ID: 35734620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma.
    Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
    World J Surg; 2007 Oct; 31(10):2016-22. PubMed ID: 17687597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma.
    Bagante F; Spolverato G; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
    Ann Surg Oncol; 2017 Sep; 24(9):2491-2501. PubMed ID: 28466403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.
    Imai K; Yamamoto M; Ariizumi S
    Hepatogastroenterology; 2010; 57(104):1333-6. PubMed ID: 21443080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center.
    Chang ME; Lei HJ; Chen MH; Yeh YC; Li CP; Hung YP; Hsia CY; Liu CA; Chau GY; Chao Y
    J Chin Med Assoc; 2017 Mar; 80(3):140-146. PubMed ID: 28169208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Uenishi T; Ariizumi S; Aoki T; Ebata T; Ohtsuka M; Tanaka E; Yoshida H; Imura S; Ueno M; Kokudo N; Nagino M; Hirano S; Kubo S; Unno M; Shimada M; Yamaue H; Yamamoto M; Miyazaki M; Takada T
    J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):499-508. PubMed ID: 24519806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma.
    Morimoto Y; Tanaka Y; Ito T; Nakahara M; Nakaba H; Nishida T; Fujikawa M; Ito T; Yamamoto S; Kitagawa T
    J Hepatobiliary Pancreat Surg; 2003; 10(6):432-40. PubMed ID: 14714164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periductal infiltrating type of intrahepatic cholangiocarcinoma: a rare macroscopic type without any apparent mass.
    Uno M; Shimada K; Yamamoto Y; Nara S; Esaki M; Sakamoto Y; Kosuge T; Ojima H
    Surg Today; 2012 Dec; 42(12):1189-94. PubMed ID: 22350300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma?
    Yamamoto M; Takasaki K; Yoshikawa T; Ueno K; Nakano M
    J Surg Oncol; 1998 Nov; 69(3):162-7. PubMed ID: 9846503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of patients with intraductal growth sub-type of intrahepatic cholangiocarcinoma.
    Bagante F; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Itaru E; Pawlik TM
    HPB (Oxford); 2018 Dec; 20(12):1189-1197. PubMed ID: 29958811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
    Shibahara H; Tamada S; Higashi M; Goto M; Batra SK; Hollingsworth MA; Imai K; Yonezawa S
    Hepatology; 2004 Jan; 39(1):220-9. PubMed ID: 14752841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement.
    Shimada K; Sano T; Nara S; Esaki M; Sakamoto Y; Kosuge T; Ojima H
    Surgery; 2009 Apr; 145(4):411-6. PubMed ID: 19303990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan.
    Sakamoto Y; Kokudo N; Matsuyama Y; Sakamoto M; Izumi N; Kadoya M; Kaneko S; Ku Y; Kudo M; Takayama T; Nakashima O;
    Cancer; 2016 Jan; 122(1):61-70. PubMed ID: 26430782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should Utilization of Lymphadenectomy Vary According to Morphologic Subtype of Intrahepatic Cholangiocarcinoma?
    Zhang XF; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Pawlik TM
    Ann Surg Oncol; 2019 Jul; 26(7):2242-2250. PubMed ID: 30927194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
    Ohtsuka M; Ito H; Kimura F; Shimizu H; Togawa A; Yoshidome H; Miyazaki M
    Br J Surg; 2002 Dec; 89(12):1525-31. PubMed ID: 12445060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology.
    Itamoto T; Asahara T; Katayama K; Nakahara H; Fukuda T; Yano M; Hino H; Nakahara M; Dohi K; Shimamoto F
    Hepatogastroenterology; 2001; 48(40):1129-33. PubMed ID: 11490816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the postoperative prognosis of intrahepatic cholangiocarcinoma (ICC): importance of preoperatively- determined anatomic invasion level and number of tumors.
    Marubashi S; Gotoh K; Takahashi H; Ohigashi H; Yano M; Ishikawa O; Sakon M
    Dig Dis Sci; 2014 Jan; 59(1):201-13. PubMed ID: 24122559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes.
    Ariizumi S; Kotera Y; Takahashi Y; Katagiri S; Chen IP; Ota T; Yamamoto M
    J Surg Oncol; 2011 Aug; 104(2):130-9. PubMed ID: 21448898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for laparoscopic liver resection of mass-forming intrahepatic cholangiocarcinoma.
    Kinoshita M; Kanazawa A; Takemura S; Tanaka S; Kodai S; Shinkawa H; Shimizu S; Murata A; Nishio K; Hamano G; Ito T; Tsukamoto T; Kubo S
    Asian J Endosc Surg; 2020 Jan; 13(1):46-58. PubMed ID: 30924307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.